The 20 Best Myelodysplastic Syndrome (MDS) Doctors Near Me in Michigan, US

Andrew Muskovitz is a Hematologist and an Oncologist in Sterling Heights, Michigan. Dr. Muskovitz has been practicing medicine for over 21 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Thrombocytopenia, Bone Marrow Aspiration, and Ureteroscopy. Dr. Muskovitz is currently accepting new patients.

Brett Brinker is a Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Brinker has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is currently accepting new patients.

Mohammed Ogaily is an Oncologist in Brownstown Twp, Michigan. Dr. Ogaily has been practicing medicine for over 39 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Angiosarcoma, Lynch Syndrome, Colorectal Cancer, and Paget Disease of the Breast. Dr. Ogaily is currently accepting new patients.

Adil Akhtar is a Palliative Medicine specialist and an Oncologist in Sterling Heights, Michigan. Dr. Akhtar has been practicing medicine for over 41 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Akhtar is currently accepting new patients.

Erin Pettijohn is a Hematologist and a Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Pettijohn has been practicing medicine for over 15 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is currently accepting new patients.

Latha Polavaram is a Hematologist and a Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Polavaram has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Polavaram is currently accepting new patients.

Deepa Jagtap is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Jagtap is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Jagtap is currently accepting new patients.

Kelly Parling is an Otolaryngologist and a Hematologist Oncology provider in Holland, Michigan. Dr. Parling has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Myelodysplastic Syndrome (MDS), and Neuroendocrine Tumor. Dr. Parling is currently accepting new patients.

Andrew Sochacki is a Hematologist Oncology specialist and an Oncologist in Grand Rapids, Michigan. Dr. Sochacki has been practicing medicine for over 12 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Sochacki is currently accepting new patients.

Stephanie Dublis is a Hematologist and an Oncologist in Grand Rapids, Michigan. Dr. Dublis has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Dublis is currently accepting new patients.

Kathryn Alguire is a Hematologist Oncology specialist and an Oncologist in Norton Shores, Michigan. Dr. Alguire has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Alguire is currently accepting new patients.

Samir Alsawah is an Oncologist in Sterling Heights, Michigan. Dr. Alsawah has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Myelodysplastic Syndrome (MDS), ALK-Positive Non-Small Cell Lung Cancer, Non-Hodgkin Lymphoma, Agranulocytosis, and Bone Marrow Aspiration. Dr. Alsawah is currently accepting new patients.

Yusuf Qamruzzaman is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Qamruzzaman has been practicing medicine for over 19 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Qamruzzaman is currently accepting new patients.

Eric Batts is a Hematologist Oncology specialist and an Oncologist in Holland, Michigan. Dr. Batts has been practicing medicine for over 25 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Batts is currently accepting new patients.

George Howard is an Oncologist in Sterling Heights, Michigan. Dr. Howard has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is currently accepting new patients.

Bhadresh Nayak is an Oncologist in Sterling Heights, Michigan. Dr. Nayak has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Protein S Deficiency, Congenital Antithrombin 3 Deficiency, Bone Marrow Aspiration, and Gastrostomy. Dr. Nayak is currently accepting new patients.

Anup Lal is a Hematologist and an Oncologist in Port Huron, Michigan. Dr. Lal has been practicing medicine for over 31 years and is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Transient Erythroblastopenia of Childhood, Pure Red Cell Aplasia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Lal is currently accepting new patients.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy.